Doctors call it a revolution

Doctors in Chicago used the word "revolution" last May after results showed a new treatment for pancreatic cancer could double patients' survival time. Rachna Shroff, an oncologist at the University of Arizona, said she cried when she saw the findings, which marked a major breakthrough in the fight against the disease.

AI-designed drugs spark new hope

The first drugs designed using artificial intelligence are now in development, signaling a new era in cancer treatment. While these drugs are not a cure, they represent a significant step forward in the battle against diseases like pancreatic cancer, which has historically been difficult to treat.

Ambitious goals for cancer treatment

Fabrice Barlesi, director general of Gustave-Roussy, aims to cure 80 percent of cancer patients by 2040. This would be a dramatic improvement from the 1990s, when only about half of patients were cured, showing the rapid progress being made in oncology.

Screening rates lag in France

Despite advances in treatment, France lags behind other countries in cancer screening. Only one in three French people participates in colorectal cancer screening, compared to nearly one in two across Europe and 74 percent in Finland. This gap highlights a critical challenge in improving cancer outcomes.

Early detection remains a priority

Barlesi emphasized that without proper screening, efforts to improve treatments may not be fully effective. He called it "madness not to undergo screening," underscoring the importance of early detection in the fight against cancer. The question remains: how can progress in treatment be matched with better efforts to detect the disease in time?